CareFusion 303, Inc. (a BD company) is recalling various BD Alaris Pump Infusion Sets used with infusion pump modules. These sets may perform outside of their intended accuracy ranges, specifically regarding flow rate, bolus delivery, and the time it takes for the system to sound an alarm during a line blockage (occlusion). The manufacturer initiated this recall via letter on September 11, 2025.
If the infusion sets deliver medication at the wrong rate or fail to alarm when a line is blocked, patients may receive too much or too little medication. This can lead to serious injury or life-threatening complications, especially for patients receiving critical medications where precise dosing is required.
Recall pertains to sets used with compatible pump infusion modules that may perform outside performance ranges for flow rate, bolus accuracy, and occlusion alarms.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.